{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:32:56Z","timestamp":1788993176495,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd005399.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000}}],"reference-count":81,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005399.pub3","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T10:21:39Z","timestamp":1441275699000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacological interventions for epilepsy in people with intellectual disabilities"],"prefix":"10.1002","volume":"2015","author":[{"given":"Cerian F","family":"Jackson","sequence":"first","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Fazakerley Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina M","family":"Makin","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust; Lower Lane Fazakerley Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Clinical Sciences Centre for Research and Education, Lower Lane Fazakerley Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kerr","sequence":"additional","affiliation":[{"name":"Hadyn Ellis Building, European Cancer Stem Cell Research, Cardiff University; Cardiff Wales UK CF24 4HQ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0387-7604(12)80052-0","article-title":"Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy","volume":"13","author":"Battaglia","year":"1991","journal-title":"Brain & Development"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1059-1311(00)90474-6","article-title":"A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy","volume":"10","author":"Crawford","year":"2001","journal-title":"Seizure"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1528-1157.1989.tb05321.x","article-title":"Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome","volume":"30","author":"Crumrine","year":"1989","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1998.tb01411.x","article-title":"The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study","volume":"39","author":"Eriksson","year":"1998","journal-title":"Epilepsia"},{"issue":"63","key":"10.1002\/14651858.CD005399.pub3-BIB0005|cit5","first-page":"417","article-title":"Ineffectiveness of add-on treatment with flunarizine in patients with epilepsy and mental retardation","volume":"62","author":"Gigli","year":"1988","journal-title":"Il Bolletino della Lega Italiana contro l'Epilessia"},{"issue":"21","key":"10.1002\/14651858.CD005399.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0007|cit7","first-page":"231","article-title":"Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation","volume":"35","author":"Kaski","year":"1991","journal-title":"Journal of Mental Deficiency Research"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.yebeh.2005.07.006","article-title":"A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life","volume":"7","author":"Kerr","year":"2005","journal-title":"Epilepsy & Behavior"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005399.pub3-BIB0009|cit9","first-page":"92","article-title":"Double-blind, placebo-controlled evaluation of the safety and efficacy of lamotrigine (Lamictal) for the treatment of patients with a clinical diagnosis of Lennox-Gastaut syndrome","volume":"37","author":"Billard","year":"1996","journal-title":"Epilepsia"},{"issue":"25","key":"10.1002\/14651858.CD005399.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005399.pub3-BIB0011|cit11","first-page":"163","article-title":"Improved neurological function accompanies effective control of the Lennox-Gastaut syndrome with Lamictal: results of a multinational, placebo-controlled trial","volume":"37","author":"Mullens","year":"1996","journal-title":"Epilepsia"},{"issue":"15","key":"10.1002\/14651858.CD005399.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study of clobazam in Lennox-Gastaut syndrome","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005399.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1111\/j.1528-1157.1994.tb05969.x","article-title":"Felbamate in the treatment of Lennox-Gastaut syndrome","volume":"35","author":"Jensen","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005399.pub3-BIB0014|cit14","first-page":"13","article-title":"A double-blind trial of felbamate in Lennox-Gastaut syndrome","volume":"32","author":"Ritter","year":"1991","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"Ritter","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0016|cit16","first-page":"63","article-title":"Clinical experience with felbamate in paediatric age","volume":"86-7","author":"Vigevano","year":"1994","journal-title":"Lega Italiana conto l'Epilessia"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005399.pub3-BIB0017|cit17","first-page":"131","article-title":"A double-blind trial of topiramate in Lennox-Gastaut syndrome (LGS)","volume":"38","author":"Glauser","year":"1997","journal-title":"Epilepsia"},{"issue":"9","key":"10.1002\/14651858.CD005399.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005399.pub3-BIB0019|cit19","first-page":"155","article-title":"The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome (LGS)","volume":"37","author":"Oletsky","year":"1996","journal-title":"Epilepsia"},{"issue":"2-3","key":"10.1002\/14651858.CD005399.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0920-1211(98)00119-3","article-title":"The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome","volume":"34","author":"Siegel","year":"1999","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3805\/jjes.15.110","article-title":"Single blind comparative study of clobazam (NH-15) with clonazepam in intractable childhood epilepsies","volume":"15","author":"Yamatogi","year":"1997","journal-title":"Journal of the Japan Epilepsy Society"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub3-BIB0022|cit22","first-page":"268","article-title":"Clonazepam: its efficacy in association with phenytoin and phenobarbital in mental patients with generalized major motor seizures","volume":"16","author":"Bielmann","year":"1978","journal-title":"International Journal of Clinical Pharmacology and Biopharmacy"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yebeh.2012.12.007","article-title":"Subclinical epileptiform activity in children with electrical status epilepticus during sleep: effects on cognition and behaviour before and after treatment with levetiracetam","volume":"27","author":"Bjornaes","year":"2013","journal-title":"Epilepsy & Behavior"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/epi.12561","article-title":"Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total seizure improvements over 3 years","volume":"55","author":"Conry","year":"2014","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1212\/01.wnl.0000230138.46508.5b","article-title":"Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures","volume":"67","author":"Donati","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005399.pub3-BIB0026|cit26","first-page":"118","article-title":"Long-term follow-up of felbamate treatment in children with Lennox-Gastaut Syndrome","volume":"33","author":"Espe-Lillo","year":"1992","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD005399.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/epi.12240","article-title":"Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures","volume":"54","author":"Gidal","year":"2013","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/0883073810390037","article-title":"Clinical and electroencephalographic effects of folinic acid treatment in Rett syndrome patients","volume":"26","author":"Hagebeuk","year":"2011","journal-title":"Journal of Child Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JCP.0b013e3181b639b4","article-title":"Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with intellectual disabilities?","volume":"29","author":"Hellings","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yebeh.2013.05.015","article-title":"Adjunctive Madopar for ultrarefractory epilepsy? Preliminary observations","volume":"28","author":"Hodoba","year":"2013","journal-title":"Epilepsy & Behavior"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1528-1157.1989.tb05322.x","article-title":"Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study","volume":"30","author":"Luna","year":"1989","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD005399.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/dmcn.12121","article-title":"The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies","volume":"55","author":"Santos","year":"2013","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"10","key":"10.1002\/14651858.CD005399.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1469-8749.1994.tb11777.x","article-title":"A simple, effective and well-tolerated treatment regime for West syndrome","volume":"36","author":"Schlumberger","year":"1994","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"231","key":"10.1002\/14651858.CD005399.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/adc.43.231.616","article-title":"Psychometric study of children with learning problems and 14-6 positive spike EEG patterns, treated with ethosuximide (Zarontin) and placebo","volume":"43","author":"Smith","year":"1968","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2014.05.016","article-title":"Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome","volume":"37","author":"Tolbert","year":"2014","journal-title":"Epilepsy & Behavior"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub3-BIB0036|cit36","first-page":"158","article-title":"Clinico-electroencephalographic evaluation of a new benzodiazepine (Ro 05-4023) by oral administration in epileptic patients by double blind technique","volume":"16","author":"Turner","year":"1970","journal-title":"Acta Neurologica Latinoamericana"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0037|cit37","unstructured":"Bjurulf B Comparing ketogenic diet with the most appropriate antiepileptic drug - a randomized study of children with mental retardation and drug resistant epilepsy www.clinicaltrials.gov\/ct\/show\/NCT00552526"},{"issue":"7","key":"10.1002\/14651858.CD005399.pub3-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001415.pub2","article-title":"Gabapentin add-on for drug-resistant partial epilepsy","author":"Al-Bachari","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1528-1157.1998.tb01373.x","article-title":"Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD005399.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00002018-200124070-00004","article-title":"Behavioural effects of the new anticonvulsants","volume":"24","author":"Besag","year":"2001","journal-title":"Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2788.1992.tb00533.x","article-title":"Behaviour and psychiatric disorders of people with mental handicaps living in the community","volume":"36","author":"Bouras","year":"1992","journal-title":"Journal of Intellectual Disability Research"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2788.2000.00270.x","article-title":"Epilepsy and intellectual disability","volume":"44","author":"Bowley","year":"2000","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1016\/0140-6736(90)90388-L","article-title":"Vigabatrin and behaviour disturbances (Letter)","volume":"335","author":"Dam","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0010-440X(97)90072-9","article-title":"Mental disorder in adults with mental retardation and epilepsy","volume":"38","author":"Deb","year":"1997","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S0790966700004948","article-title":"Characteristics of epilepsy in a population based cohort of adults with learning disability","volume":"16","author":"Deb","year":"1999","journal-title":"Irish Journal of Psychological Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005399.pub3-BIB0046|cit46","first-page":"S30","article-title":"Vigabatrin in childhood epilepsy","volume":"6","author":"Dulac","year":"1991","journal-title":"Journal of Child Neurology"},{"issue":"10","key":"10.1002\/14651858.CD005399.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.139.10.1297","article-title":"Psychiatric disorders in the mentally retarded: types, problems, and challenges","volume":"139","author":"Eaton","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub3-BIB0048|cit48","first-page":"123","article-title":"The mentally handicapped person with epilepsy: a comparative study investigating psychosocial functioning","volume":"33","author":"Espie","year":"1989","journal-title":"Journal of Mental Deficiency Research"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub3-BIB0049|cit49","first-page":"351","article-title":"Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community","volume":"34","author":"Espie","year":"1990","journal-title":"Journal of Mental Deficiency Research"},{"issue":"8","key":"10.1002\/14651858.CD005399.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1528-1157.1998.tb01183.x","article-title":"Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation","volume":"39","author":"Ettinger","year":"1998","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0920-1211(90)90079-B","article-title":"Epilepsy in a population of mentally retarded children and adults","volume":"6","author":"Forsgren","year":"1990","journal-title":"Epilepsy Research"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD005399.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.2466\/pr0.1995.77.3f.1208","article-title":"Behavioural effects of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"77","author":"Gay","year":"1995","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-3148.1989.tb00022.x","article-title":"The social and behavioural functioning of people with mental handicaps attending adult training centres: a comparison with those with and without epilepsy","volume":"2","author":"Gillies","year":"1989","journal-title":"Mental Handicap Research"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1528-1157.1991.tb04711.x","article-title":"Epilepsy in children with mental retardation: a cohort study","volume":"34","author":"Goulden","year":"1991","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0055|cit55","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-8749.1984.tb04399.x","article-title":"The development of psychiatric disorder among school children with epilepsy","volume":"26","author":"Hoare","year":"1984","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Commission on Classification and Terminology of the ILAE: proposal for revised clinical and EEG classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Commission on Classification and Terminology of the ILAE: proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1059-1311(97)80032-5","article-title":"Learning disability and epilepsy","volume":"6","author":"Kerr","year":"1997","journal-title":"Seizure"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3476(96)70336-0","article-title":"Efficacy of gabapentin therapy in children with refractory partial seizures","volume":"128","author":"Khurana","year":"1996","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1528-1157.1996.tb00517.x","article-title":"Behavioral side effects of gabapentin in children","volume":"37","author":"Lee","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0063|cit63","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0064|cit64","volume-title":"Services for People with Learning Disabilities and Challenging Behaviour or Mental Health Needs","author":"Mansell","year":"1993"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0065|cit65","first-page":"27","article-title":"Epilepsy in institutionalized patients with encephalopathy: clinical aspects and nosological considerations","volume":"98","author":"Mariani","year":"1993","journal-title":"American Journal of Mental Retardation"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004154.pub4","article-title":"Clobazam as an add-on in the management of refractory epilepsy","author":"Michael","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0067|cit67","first-page":"57","article-title":"Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability","volume":"1","author":"Mikati","year":"1998","journal-title":"Journal of Intellectual Disability Research"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1352\/0895-8017(2003)108<293:POEAAH>2.0.CO;2","article-title":"Prevalence of epilepsy and associated health service utilization and mortality among patients with intellectual disability","volume":"108","author":"Morgan","year":"2003","journal-title":"American Journal of Mental Retardation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD005399.pub3-BIB0069|cit69","first-page":"163","article-title":"Improved neurological function accompanies effective control of the Lennox-Gastaut syndrome with Lamictal: results of a multinational, placebo-controlled trial","volume":"37","author":"Mullens","year":"1996","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001417.pub3","article-title":"Topiramate add-on for drug-resistant partial epilepsy","author":"Pulman","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001909","article-title":"Lamotrigine add-on for drug-resistant partial epilepsy","author":"Ramaratnam","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0072|cit72","first-page":"4576","article-title":"Management of chronic epilepsy","volume":"345","author":"Rugg-Gunn","year":"2012","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0073|cit73","first-page":"511","article-title":"Epilepsy in school children with intellectual impairments in Sheffield: the size and nature of the problem and its implications in service provision","volume":"33","author":"Shepherd","year":"1989","journal-title":"Journal of Mental Deficiency Research"},{"issue":"7","key":"10.1002\/14651858.CD005399.pub3-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008295.pub3","article-title":"Felbamate as an add-on therapy for refractory epilepsy","author":"Shi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0075|cit75","first-page":"12","article-title":"Epilepsy in Down's syndrome: clinical aspects and possible mechanisms","volume":"98","author":"Stafstrom","year":"1993","journal-title":"American Journal of Mental Retardation"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2011.03044.x","article-title":"A prospective case control study of psychiatric disorders in adults with epilepsy and intellectual disability","volume":"52","author":"Turky","year":"2011","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00002018-199615060-00003","article-title":"A comparative review of the adverse effects of anticonvulsants in children with epilepsy","volume":"15","author":"Wallace","year":"1996","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD005399.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jmg.28.6.395","article-title":"On the incidence of fits and mental retardation in tuberous sclerosis","volume":"6","author":"Webb","year":"1991","journal-title":"Journal of Medical Genetics"},{"issue":"12","key":"10.1002\/14651858.CD005399.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1528-1157.1995.tb01063.x","article-title":"Gabapentin toxicity in children manifesting as behavioural changes","volume":"36","author":"Wolf","year":"1995","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005399.pub2","article-title":"Pharmacological interventions for epilepsy in people with intellectual disabilities","author":"Beavis","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub3-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005399.pub2","article-title":"Pharmacological interventions for epilepsy in people with intellectual disabilities","author":"Beavis","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005399.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T16:05:13Z","timestamp":1655913913000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005399.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":81,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005399.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}